Schizophrenia News and Research

Latest Schizophrenia News and Research

New schizophrenia treatment

Schizophrenia is one of the most debilitating of the major psychiatric disorders, and is also one of the most difficult to treat.

14 Dec 2007

New studies on brain and behavior from the world's leading scientists

The 2007 American College of Neuropsychopharmacology Annual Meeting will feature hundreds of new studies on brain and behavior from the world's leading scientists.

10 Dec 2007

Brain differences found in adolescents with mental illness

Puberty may have an impact on areas of the brain that contribute to bipolar disorder or schizophrenia in youth, according to a study presented at the annual meeting of the American College of Neuropsychopharmacology (ACNP).

10 Dec 2007

Possible genetic link between schizophrenia and cancer

A series of studies presented today at the American College of Neuropsychopharmacology (ACNP) annual meeting elucidates evidence that there is a genetic link between schizophrenia and cancer, providing a surprising possible scientific explanation for lower rates of cancer among patients with schizophrenia – despite having poor diets and high rates of smoking – and their parents.

10 Dec 2007

Genetic markers for mental illness

Researchers have discovered natural genetic differences that might help predict the most effective antipsychotic drugs for particular patients with mental disorders such as schizophrenia, Parkinson's and drug addiction.

4 Dec 2007

New genetic markers found that increase a person's risk for schizophrenia

Scientists at the Zucker Hillside Hospital campus of the Feinstein Institute for Medical Research have identified nine genetic markers that can increase a person's risk for schizophrenia.

4 Dec 2007

Why do mental illness and drug addiction so often go together?

New research reveals that this type of dual diagnosis may stem from a common cause: developmental changes in the amygdala, a walnut-shaped part of the brain linked to fear, anxiety and other emotions.

3 Dec 2007

Scientists adopt fresh approach in quest for new therapies

Scientists are to pool their expertise in human health to pioneer an innovative approach to treating common diseases.

27 Nov 2007

Nicotine patches can enhance cognitive function among newly recovering alcoholics with a history of smoking

Detoxified alcoholics in the early stages of recovery tend to have impaired cognitive functioning.

27 Nov 2007

FDA accepts Schering-Plough's new drug application for Asenapine

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) recently accepted the filing for review of the New Drug Application (NDA) for asenapine, a fast-dissolving, sublingual tablet.

26 Nov 2007

New discoveries about nitric oxide can provide drugs for schizophrenia

Problems with memory and social function in patients with schizophrenia may result from an imbalance in the brain’s nitric oxide system.

21 Nov 2007

Molecular foreman discovered for brain wiring

Researchers have identified a master regulatory molecule that is responsible for triggering the remodeling of neuronal connections that is critical for learning.

21 Nov 2007

People with schizophrenia are more likely to suffer from ruptured appendix

People with mental illness suffer more than just psychological problems. People with schizophrenia are more likely to suffer from ruptured appendix than others, according to research published in the online open access journal, BMC Public Health.

16 Nov 2007

Drug to treat children with bipolar disorder gets priority review

An anti-psychotic drug already approved in the U.S. to treat adults and adolescents with schizophrenia may soon be available for youngsters age 10 to 17 years of age suffering from bipolar disorder.

15 Nov 2007

Long term use of Ritalin ineffective and may stunt childrens growth

The latest research from the U.S. says the long-term use of drugs such as Ritalin and Concerta for the treatment of children with Attention Deficit Hyperactivity Disorder (ADHD) is not effective.

13 Nov 2007

New genetic schizophrenia link found

Schizophrenia is a debilitating psychiatric illness. Its cause is currently poorly understood, and there is no known cure.

13 Nov 2007

Selective resequencing provides low-cost method for interpreting human genome

Cold Spring Harbor, NY Scientists at Cold Spring Harbor Laboratory (CSHL) have developed a new means of extracting and interpreting data from the human genome that is more powerful and more economical than methods currently employed.

6 Nov 2007

Prazosin curbs brain damage from post-traumatic stress disorder

A drug used to treat high blood pressure and enlargement of the prostate may protect the brain from damage caused by post-traumatic stress disorder, Alzheimer's disease, depression and schizophrenia.

6 Nov 2007

Oregon receives $1.2 million to provide rent, support services for HIV-positive people living with mental illnesses

The HIV Care and Treatment Program in the Oregon Department of Human Services recently received a three-year, $1.2 million grant from the U.S. Department of Housing and Urban Development to provide support services and rental housing for HIV-positive people living with mental illnesses, the Eugene Register-Guard reports.

5 Nov 2007

Key findings for all veterans seen in depression and suicide study

The largest and most up-to-date study of suicides among depressed veterans provides important new data that may help guide screening and treatment for all veterans.

31 Oct 2007